ABOUT COMPANY :
Emcure Pharmaceuticals Ltd. was incorporated on 16th April, 1981. The Group has emerged as significant force in manufacturing and marketing both in India and Globally.
The core strength lies in developing and manufacturing differentiated pharmaceutical products in – house and commercializing the same through marketing infrastructure across the geographies.
The group is ranked as the 12th largest Pharmaceutical company (source: AIOCD-AWACS MAT MAR 19) in India.
The Group has emerged as a leader in various therapy segments like Cardiology, Pain and Analgesics, HIV, Gynecology, Nephrology, Cephalosporin Injectable, Hepatology, Oncology, Diabetology, Vitamins – Minerals & Nutrients as well as Blood products.
The group has gained significant advantage due to its diversified / specialized group companies like Zuventus, Gennova and Heritage. Headed by a professional team each of this group has utilized their own strengths across therapy segments and geographies and know-how to make the group stronger and well entrenched.
The group products are available globally over 65 countries and enjoy the alliance of local and multinational companies to attain leadership.
The group has subsidiaries in Dubai, Brazil, South Africa, Singapore and Nigeria and branch offices in Russia, Morocco and Shanghai.
The group has nine manufacturing facilities including eight in India and one in United States, five of which are approved by USFDA.
Our quality is respected in India and world over and is testimonial of our supplies to leading multinationals.
Our group is respected as a reliable and proven co- marketing partner, evident through our collaborative relationship with companies like Sanofi, Roche, B.M.S etc.
We offer technological expertise across various areas like API’s (First to market opportunities in domestic markets), Bio Similars, Novel Drug Delivery Systems, Paragraph IV opportunities in US, wide expertise with various dosage forms, Chiral molecules, Peptides, Polymer based chemistry & complex products.
Through Zuventus the group has emerged as a leader in Acute & Semi Chronic therapies in Indian Pharmaceutical Market. For further info click and access www.emcure.co.in
The core strength lies in developing and manufacturing differentiated pharmaceutical products in – house and commercializing the same through marketing infrastructure across the geographies.
The group is ranked as the 12th largest Pharmaceutical company (source: AIOCD-AWACS MAT MAR 19) in India.
The Group has emerged as a leader in various therapy segments like Cardiology, Pain and Analgesics, HIV, Gynecology, Nephrology, Cephalosporin Injectable, Hepatology, Oncology, Diabetology, Vitamins – Minerals & Nutrients as well as Blood products.
The group has gained significant advantage due to its diversified / specialized group companies like Zuventus, Gennova and Heritage. Headed by a professional team each of this group has utilized their own strengths across therapy segments and geographies and know-how to make the group stronger and well entrenched.
The group products are available globally over 65 countries and enjoy the alliance of local and multinational companies to attain leadership.
The group has subsidiaries in Dubai, Brazil, South Africa, Singapore and Nigeria and branch offices in Russia, Morocco and Shanghai.
The group has nine manufacturing facilities including eight in India and one in United States, five of which are approved by USFDA.
Our quality is respected in India and world over and is testimonial of our supplies to leading multinationals.
Our group is respected as a reliable and proven co- marketing partner, evident through our collaborative relationship with companies like Sanofi, Roche, B.M.S etc.
We offer technological expertise across various areas like API’s (First to market opportunities in domestic markets), Bio Similars, Novel Drug Delivery Systems, Paragraph IV opportunities in US, wide expertise with various dosage forms, Chiral molecules, Peptides, Polymer based chemistry & complex products.
Through Zuventus the group has emerged as a leader in Acute & Semi Chronic therapies in Indian Pharmaceutical Market. For further info click and access www.emcure.co.in
For more updates follow
To get global pharma news updates in whatsapp please
No comments:
Post a Comment